Affiliation:
1. Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
Abstract
Abstract:
Quinoxaline molecule has gathered great attention in medicinal chemistry due to its vide
spectrum of biological activities and has emerged as a versatile pharmacophore in drug discovery
and development. Its structure comprises a bicyclic ring of benzopyrazine and displays a range of
pharmacological properties, including antibacterial, antifungal, antiviral, anticancer, and antiinflammatory.
This study aims to summarize the different strategies for the synthesis of quinoxalines
and their anti-inflammatory properties acting through different mechanisms. Structure-activity
relationships have also been discussed in order to determine the effect of structural modifications on
anti-inflammatory potential. These analyses illuminate critical structural features required for optimal
activity, driving the design and synthesis of new quinoxaline analogues with better antiinflammatory
activities. The anti-inflammatory properties of quinoxalines are attributed to their inhibitory
action on the expression of several inflammatory modulators such as cyclooxygenase, cytokines,
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) and p38α Mitogen
Activated Protein Kinase (p38α MAPK). Activators of nuclear factor erythroid 2–related factor 2
(NRF2) and agonistic effect on opioid receptors have also been discussed. Hence, this study may
provide a future template for the design and development of novel quinoxaline derivatives acting
through different molecular targets as potential anti-inflammatory agents with better efficacy and
safety profiles.
Publisher
Bentham Science Publishers Ltd.